Drug recall · August 19, 2020
Lidocaine Patch 5% recall
Why: Labeling: Incorrect or Missing Lot and/or Exp date on the individual transdermal pouches but not in the carton.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Lidocaine Patch 5%, packaged in 30-count cartons, Rx only, Manufactured by: Actavis Laboratories UT, Inc., Salt Lake City, UT 84108, USA, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054 USA, NDC 0591-3525-30
- Lots / codes
Carton Lot # 1383513B, Patch Lot # 1383513, Exp date 03/2022
- Quantity
- 28,596 cartons
- Company
- Teva Pharmaceuticals USA, Parsippany, NJ
- Distribution
- Nationwide United States
- Initiated
- July 14, 2020 · Voluntary: Firm initiated
- Classified
- August 10, 2020
- Reported
- August 19, 2020
- Ended
- July 7, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lidocaine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.